If you're seeing this message, that means JavaScript has been disabled on your browser.Please enable JavaScript to make this website work.

DAJO BIO (达加生物)

Shenzhen, China

Biopharmaceutical

11 – 50

DAJO BIO (达加生物) focuses on the research and development of next-generation TCR (T cell receptor) protein drugs.

Unlock unlimited company data

As our subscriber, you can search and filter over 100,000 companies for your fundraising, investing, or sales needs.

Just $0.17 per day

Our subscriber community includes professionals from these companies:

2 – 10 employees

0 job positions

Tired of ads? Enjoy an ad-free experience by signing up.